Weiguo Hu

ORCID: 0000-0002-8614-0359 · 3 papers in corpus · active 2009-2013

Study types

  • article 3

Condition tags

  • endometriosis 3
  • endometrioma 1
  • dyspareunia 1
article 2013
Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway.
International journal of clinical and experimental pathology

Evidence for an immunosuppressive function of indoleamine 2,3-dioxygenase (IDO) has been accumulating. However, the unusual distribution of IDO1 in gynecologic cancer cells suggests that modulating immunity may not its only function. To cla…

article 2010
[Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Zhonghua fu chan ke za zhi

OBJECTIVE: To compare clinical effect of gonadotropin releasing hormone agonist (GnRH-a) alone and GnRH-a combined with low-dose dydrogesteronea and estradiol valerate on sex hormone, hypoestrogenic symptoms, quality of life and bone minera…

article 2009
[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.issn.0529-567x.2009.07.007

OBJECTIVE: To evaluate effects and safety of gonadotrophin-releasing hormone agonist (GnRH-a) combined with transdermal estradiol and medroxyprogesterone acetate in the treatment of endometriosis. METHODS: From January 1st, 2007 to July 31s…